| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |